Subsequent knockdown and immunoprecipitation studies revealed that RASSF1A likely exerts its tumour suppressor effect by PP2A mediated dephosphorylation of GEF-H1 allowing subsequent stimulation of RhoB [128]. The gene discussed is ARHGEF2; the disease is neoplasm.